Fig. 1From: Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapyAverage proliferation over time for ovarian cancer cells treated with azacitidine, carboplatin and combination azacitidine and carboplatin. Data displayed is mean ± SEM of triplicates of three independent experiments for 8 cell linesBack to article page